Shree Ganesh Bio-Tech (India) Ltd

NSE: SHREEGANES · BSE: 539470 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹0.47
Market cap: ₹18.74 Cr
Revenue (annual): ₹4.97 Cr
Net profit (annual): ₹0.38 Cr
P/E (TTM): -48.5×Sector 47.3×
Promoter holding: 0.00%+0.00% QoQ
FII holding: 1.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Other Announcement 3 Board Meeting Date 2 Debt & Borrowing 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

23 Apr 2026 18:21 IST BSE

Debt & Borrowing

Shree Ganesh Bio-Tech (India) Debt & Borrowing

Shree Ganesh Biotech (India) Ltd confirmed it does not meet the SEBI criteria for a 'Large Corporate' as of March 31, 2026. The company reported zero outstanding borrowings. Consequently, it is exempt from mandatory debt fundraising disclosures and compliance norms specified for Large Entities under SEBI circulars.

Read the filing ↗